DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Merrimack Pharmaceuticals, Inc. (MACK)
« Back to company indexMACK Chatter Timeline
Stock Ticker for MACK
Most Active Tweeters for MACK
| User | Tweets |
|---|---|
| @Gambiste1 | 3 |
| @itchibahn | 2 |
| @DFWCheapHouses | 1 |
| @SuicideSaint666 | 1 |
Recent Tweets for MACK
 |
@Gambiste1 RT @itchibahn: $MACK Interesting as there were no insider activity since 9/15/2017, and then suddenly they are buying in 2019. https://t.co… June 14th 2019, 2:06pm |
|
@Gambiste1 RT @itchibahn: $MACK closed out Sep20 7.00 Covered Calls, +260% 4few months of hold but only 16 contracts. June 14th 2019, 2:06pm |
 |
@itchibahn $MACK Interesting as there were no insider activity since 9/15/2017, and then suddenly they are buying in 2019. https://t.co/TKjNqVcZQa June 14th 2019, 2:06pm |
|
@itchibahn $MACK closed out Sep20 7.00 Covered Calls, +260% 4few months of hold but only 16 contracts. June 14th 2019, 1:06pm |
|
@Gambiste1 RT @SuicideSaint666: I Woke Up In THe Morning, Bru$H My TeetH $mack My BitcH Ass. June 7th 2019, 8:06am |
 |
@SuicideSaint666 I Woke Up In THe Morning, Bru$H My TeetH $mack My BitcH Ass. June 7th 2019, 3:06am |
 |
@DFWCheapHouses $MACK good volume today June 5th 2019, 2:06pm |
 |
@SweetNaeJones I’m old school . . . & I’ll $mack a bih June 1st 2019, 5:06pm |
 |
@mergerpie Merrimack -2.6% as it decides against sale https://t.co/CwTnKs9fME $MACK May 31st 2019, 8:05pm |
 |
@ontargt Merrimack winding down operations $mack https://t.co/lwVCnhkSEm May 31st 2019, 2:05pm |
 |
@OpenOutcrier $MACK (-3.8% pre) Merrimack Pharma Announces Completion of Strategic Review, Preservation of Ipsen Milestones and S… https://t.co/hySXHkmntG May 31st 2019, 8:05am |
 |
@StockNewsWires $MACK: Merrimack axes remaining staff, execs after selling assets to New …: https://t.co/ddKv3RzD7g May 31st 2019, 6:05am |
 |
@MarketChmln $MACK $MACK declines in after hours trading. See the latest news. https://t.co/JX5ozarAnY https://t.co/IqFLW0Jp1V May 30th 2019, 7:05pm |
 |
@1MinuteStock Btw, Estimated #Earnings Per Share for $MACK is $-1.36 it's -22.04% of the current price https://t.co/zk74RIE8x2 May 30th 2019, 5:05pm |
 |
@newswithvalue $MACK: Merrimack -2.6% as it decides against sale: https://t.co/wmOrSayaeQ May 30th 2019, 5:05pm |
 |
@BosBizAllison After shelving its sole drug candidate, @MerrimackPharma has ruled out a sale of the company. Background: https://t.co/sf7FTBmawG $MACK May 30th 2019, 5:05pm |
 |
@MarketCurrents $MACK - Merrimack -2.6% as it decides against sale https://t.co/JPOxEw86QJ May 30th 2019, 5:05pm |
 |
@StockNewsNow $MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Spec… https://t.co/3NXTWgBU01 May 30th 2019, 5:05pm |
 |
@pnani456 RT @TraderTexMex: $MACK negative news, management couldn't find any buyers for the company "determined not to move forward with any of them… May 30th 2019, 4:05pm |
 |
@TraderTexMex $MACK negative news, management couldn't find any buyers for the company "determined not to move forward with any o… https://t.co/iqpa690g2l May 30th 2019, 4:05pm |
 |
@Stock_News_Now $MACK: New SEC Filing for MACK: Form 8-K (No. 0001193125-19-161299): https://t.co/QpzzVHY9XE May 30th 2019, 4:05pm |
 |
@fintel_io Also, if you are new to $MACK here's some background for you https://t.co/oujiVpwJnQ May 30th 2019, 4:05pm |
 |
@confcalltran Merrimack Pharmaceuticals Announces Completion Of Strategic Review, Preservation Of Ipsen https://t.co/jfTeu3Rx7Q $MACK May 30th 2019, 4:05pm |
 |
@MKsecalerts $MACK - Current Report Filing (8-k) https://t.co/kVa7hqRo3s May 30th 2019, 4:05pm |
 |
@filingsdb New Form 8-K filed by MERRIMACK PHARMACEUTICALS INC $MACK - https://t.co/oNjolawB9q May 30th 2019, 4:05pm |
 |
@NewsToDesk $MACK: Merrimack Pharmaceuticals Announces Completion of Strategic …: https://t.co/3a4BGiQmbN May 30th 2019, 4:05pm |
 |
@ez_alertz $MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Spec… https://t.co/CyQL4Vjnz9 May 30th 2019, 4:05pm |
 |
@Allstocknews $MACK Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones an From our Stock News Alerts App May 30th 2019, 4:05pm |
|
@MKsecalerts $MACK - Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones https://t.co/mPYtMAsZ7c May 30th 2019, 4:05pm |
 |
@betrbiz $MACK earnings tomorrow. Hate holding through earnings unless it's positive news then it's all good lol! May 28th 2019, 6:05pm |
 |
@bulletin_en Moderna Inc. $MACK Contrasting side by side https://t.co/mSHol2nhXY May 23rd 2019, 2:05pm |
|
@bulletin_en Entera Bio Ltd. $MACK Contrasting side by side https://t.co/PiS2ElCSp0 May 23rd 2019, 8:05am |
 |
@SwingTradeBot Recent $MACK technical alerts: Hammer Candlestick plus 6 more alerts... https://t.co/lR5hdjMVt5 May 21st 2019, 3:05pm |
|
@bulletin_en Aileron Therapeutics Inc. $MACK Comparing side by side https://t.co/euc1G5lpZu May 21st 2019, 10:05am |
 |
@FinZTribune Novo Nordisk A/S $MACK Contrasting side by side https://t.co/2le3rDGfEo May 17th 2019, 7:05pm |
|
@fintel_io Newtyn Management, LLC has filed an amended 13G/A, reporting 8.9% ownership in $MACK - https://t.co/YUCHHBdyxP May 13th 2019, 4:05pm |
|
@Allstocknews $MACK New Form SC 13G/A for Merrimack Pharmaceuticals From our Stock News Alerts App May 13th 2019, 4:05pm |
 |
@ez_forms $MACK Newtyn Management, LLC Discloses 8.9% Passive Ownership in MERRIMACK PHARMACEUTICALS INC Form: 13G/A Filing: https://t.co/FSFCgoz0XG May 13th 2019, 4:05pm |
|
@Stock_News_Now $MACK: New SEC Filing for MACK: Form SC 13G/A (No. 0000905718-19-000433): https://t.co/XW3v4NiwE4 May 13th 2019, 4:05pm |
|
@MKsecalerts $MACK - Amended Statement of Ownership (sc 13g/a) https://t.co/2cwPCxWtb6 May 13th 2019, 4:05pm |
 |
@RoccoLefkowitz Covered all 2000 $MACK at 5.85 for profit of $700, seems to be holding steady in a sea of red. May 13th 2019, 3:05pm |
 |
@macondailynews Merrimack Pharmaceuticals $MACK Releases Quarterly Earnings Results, Beats Expectations By $0.14 EPS https://t.co/s9EvhNh66m May 12th 2019, 10:05am |
 |
@TheMarketsDaily Merrimack Pharmaceuticals $MACK Releases Quarterly Earnings Results https://t.co/Rzb9iP9jtk May 11th 2019, 12:05pm |
 |
@WeekHerald Merrimack Pharmaceuticals $MACK Announces Earnings Results https://t.co/tVSpmx2FXl May 11th 2019, 11:05am |
 |
@AmericanBanking Merrimack Pharmaceuticals $MACK Issues Earnings Results, Beats Expectations By $0.14 EPS https://t.co/4GFoZnVe0o #stocks May 11th 2019, 11:05am |
|
@StockNewsNow $MACK Merrimack Reports First Quarter 2019 Financial Results https://t.co/HyhCHP79wT May 10th 2019, 11:05am |
|
@Allstocknews $MACK New Form 10-Q for Merrimack Pharmaceuticals From our Stock News Alerts App May 10th 2019, 8:05am |
|
@1MinuteStock We calculated 21-day Expected Return of $MACK for you: 2.94% https://t.co/rerLbd8rQp May 10th 2019, 8:05am |
 |
@StockTexts $MACK Merrimack Pharmaceuticals, Inc. SEC Filing: Form 10-Q https://t.co/SlKfRy6Qa3 May 10th 2019, 8:05am |
|
@MKsecalerts $MACK - Quarterly Report (10-q) https://t.co/dgZHj0y0VR May 10th 2019, 8:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.